Jeff Ferguson, PhD

Dr. Ferguson has more than 35 years of regulatory toxicology experience in the pharmaceutical, chemical and CRO industries.  Prior to joining Aclairo in 2021, he was US Head of Toxicology at GlaxoSmithKline where he contributed to multiple drug development programs for both small and large molecules in a variety of therapeutic areas including oncology, respiratory, immune and infectious diseases, and dermatology.  He has been responsible for the appropriate design, conduct, interpretation and reporting of nonclinical safety and pharmacokinetic/toxicokinetic studies.  As a safety assessment representative to many drug development teams, Jeff has been responsible for developing and managing the respective nonclinical safety testing plans including addressing safety-related issues and writing nonclinical sections of regulatory documents.  Jeff has broad-based experience working with CROs and external development partners both as a sponsor and a consultant and has conducted due diligence on assets in various stages of development.